NCT05275075View on ClinicalTrials.gov

Identify microRNAs in Cachexia in Pancreatic Carcinoma

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 7, 2022

Primary Completion Date

May 1, 2026

Study Completion Date

May 1, 2029

Conditions
Resectable Pancreatic Adenocarcinoma
Interventions
OTHER

Pancreatic cancer microRNA and messenger RNA expression.

Tumor specimens from pancreatic patients will be analyzed for markers associated with muscle loss.

Trial Locations (1)

73117

RECRUITING

Stephenson Cancer Center, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER